6VBN

Crystal Structure of hTDO2 bound to inhibitor GNE1

6VBN の概要

• エントリーDOI: 10.2210/pdb6vbn/pdb
• 分子名称: Tryptophan 2,3-dioxygenase, PROTOPORPHYRIN IX CONTAINING FE, 1,5-anhydro-2,3-dideoxy-3-[(5S)-5H-imidazo[5,1-a]isoindol-5-yl]-D-threo-pentitol, ... (4 entities in total)
• 機能のキーワード: tdo, ido, cancer immunotherapy, heme, oxidoreductase, oxidoreductase-inhibitor complex, oxidoreductase/inhibitor
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 185534.04

構造登録者

Harris, S.F.,Oh, A. (登録日: 2019-12-19, 公開日: 2020-05-06, 最終更新日: 2023-10-11)

• 主引用文献: Parr, B.T.,Pastor, R.,Sellers, B.D.,Pei, Z.,Jaipuri, F.A.,Castanedo, G.M.,Gazzard, L.,Kumar, S.,Li, X.,Liu, W.,Mendonca, R.,Pavana, R.K.,Potturi, H.,Shao, C.,Velvadapu, V.,Waldo, J.P.,Wu, G.,Yuen, P.W.,Zhang, Z.,Zhang, Y.,Harris, S.F.,Oh, A.J.,DiPasquale, A.,Dement, K.,La, H.,Goon, L.,Gustafson, A.,VanderPorten, E.C.,Mautino, M.R.,Liu, Y.; Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors.; Acs Med.Chem.Lett., 11:541-549, 2020; PubMed: 32292562; DOI: 10.1021/acsmedchemlett.0c00004

実験手法

X-RAY DIFFRACTION (3.18 Å)